Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 63, Issue 7, Pages 853-867
Publisher
Oxford University Press (OUP)
Online
2016-09-13
DOI
10.1093/cid/ciw566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness
- (2015) Cameron M Wright et al. BMC INFECTIOUS DISEASES
- Optimal Duration of Anti-TB Treatment in Patients With Diabetes
- (2015) Jann-Yuan Wang et al. CHEST
- The impact of sputum quality on tuberculosis diagnosis: a systematic review
- (2015) J. Ho et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Global and Regional Burden of Isoniazid-Resistant Tuberculosis
- (2015) C. M. Yuen et al. PEDIATRICS
- Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America
- (2014) H. Masur et al. CLINICAL INFECTIOUS DISEASES
- Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy
- (2014) G. Narendran et al. CLINICAL INFECTIOUS DISEASES
- Smoking adversely affects treatment response, outcome and relapse in tuberculosis
- (2014) Chi C. Leung et al. EUROPEAN RESPIRATORY JOURNAL
- Microcytic Anemia
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen
- (2014) Kyung-Wook Jo et al. RESPIRATORY MEDICINE
- Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE
- (2013) Anne F. Luetkemeyer et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis
- (2013) Julia A Critchley et al. LANCET INFECTIOUS DISEASES
- An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse
- (2013) Patrick P. J. Phillips et al. PLoS One
- Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis
- (2012) Amitabh B Suthar et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- An Updated Systematic Review and Meta-analysis on the Treatment of Active Tuberculosis in Patients With HIV Infection
- (2012) F. Ahmad Khan et al. CLINICAL INFECTIOUS DISEASES
- European Union Standards for Tuberculosis Care
- (2012) G.B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- The chemotherapy of tuberculosis: past, present and future [State of the art]
- (2012) D. Mitchison et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- The impact of diabetes on tuberculosis treatment outcomes: A systematic review
- (2011) Meghan A Baker et al. BMC Medicine
- Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
- (2011) Helen E. Jenkins et al. PLoS One
- Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
- (2010) Graeme Meintjes et al. AIDS
- The Best Approach to Reintroducing Tuberculosis Treatment after Hepatotoxicity Is Still Open to Debate
- (2010) Kwok Chiu Chang et al. CLINICAL INFECTIOUS DISEASES
- Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced Hepatotoxicity
- (2010) Surendra K. Sharma et al. CLINICAL INFECTIOUS DISEASES
- Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis
- (2010) David J Horne et al. LANCET INFECTIOUS DISEASES
- Corticosteroids (dexamethasoneversusintravenous methylprednisolone) in patients with tuberculous meningitis
- (2009) H. S. Malhotra et al. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
- British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children
- (2009) Guy Thwaites et al. JOURNAL OF INFECTION
- Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Isoniazid-Monoresistant Tuberculosis in the United States, 1993 to 2003
- (2008) Andrea J. Hoopes et al. ARCHIVES OF INTERNAL MEDICINE
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
- (2008) Graeme Meintjes et al. LANCET INFECTIOUS DISEASES
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started